ValueQ3, 24Q4, 24Q1, 25Q2, 25TTMSelling/general/admin expenses151.27 M196.64 M116.21 M113.69 M577.81 MResearch & development24.58 M26.03 M24.24 M23.13 M97.98 MOperating income38.71 M-23.86 M47.66 M54.46 M116.97 MNon-Operating Income, Total434 K-1.37 M333 K3.68 M3.08 MInterest expense, net of interest capitalized2.01 M2.18 M2.93 M2.17 M9.29 MNon-Operating Income, excl. Interest Expenses-1.57 M-7 000-2.6 M1.51 M-2.67 MUnusual income/expense—-3.54 M———Pretax income38.27 M-22.86 M47.99 M50.78 M114.19 MEquity in earnings-251 K1.11 M294 K110 K1.26 MTaxes15.69 M-5.18 M9.81 M12.78 M33.09 MNon-controlling/minority interest—0———After tax other income/expense—————Net income before discontinued operations22.59 M-17.68 M40.78 M38.01 M83.7 MDiscontinued operations——-2.6 M0—Net income22.59 M-17.68 M38.19 M38.01 M81.1 MDilution adjustment—————Preferred dividends—————Diluted net income available to common stockholders22.58 M-17.7 M38.18 M38 M81.06 MBasic earnings per share (Basic EPS)0.15-0.10.250.240.54Diluted earnings per share (Diluted EPS)0.14-0.110.240.240.51Average basic shares outstanding158.12 M157.52 M155.46 M155.65 M626.75 MDiluted shares outstanding160.66 M159.72 M156.36 M156.75 M633.49 MEBITDA66.28 M3.25 M72 M79.17 M220.7 MEBIT38.71 M-23.86 M47.66 M54.46 M116.97 MCost of revenue101.63 M118.15 M98.44 M104.6 M422.82 MOther cost of goods sold—————Depreciation & amortization (cash flow)27.57 M27.11 M24.34 M24.71 M103.73 M
Bio-Techne Corp
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.